Our Pricing

Where To Buy Wegovy UK: Complete Monthly Cost Guide

Published on: June 03, 2026

Searching for where to buy Wegovy UK with transparent pricing and legitimate UK prescribers? At Cured Pharmacy, Wegovy (semaglutide) weight loss injections start from £79.00 per month, with all prices shown upfront before your free clinical consultation. Our UK-registered pharmacy (GPhC 9012511) dispenses only genuine, MHRA-licensed Wegovy pens, delivered discreetly to your door.

Where To Buy Wegovy UK: Legitimate Sources

Wegovy is a prescription-only medication in the UK, meaning it can only be legally obtained through a registered pharmacy after clinical assessment by a UK prescriber. The Medicines and Healthcare products Regulatory Agency (MHRA) strictly regulates semaglutide products to ensure patient safety [1].

When choosing where to buy Wegovy UK, verify the pharmacy is registered with the General Pharmaceutical Council (GPhC). At Cured Pharmacy, our registration number (9012511) and superintendent pharmacist Tarun Kumar (GPhC 2233073) are publicly listed, ensuring full regulatory compliance and patient protection.

Avoid unregulated websites offering Wegovy without prescriptions or at suspiciously low prices. These sources often supply counterfeit or unlicensed products that may contain incorrect dosages or harmful contaminants. Legitimate UK pharmacies will always require a clinical consultation before dispensing semaglutide injections.

Wegovy Monthly Cost UK: Complete Price Breakdown

The monthly cost of Wegovy in the UK varies depending on your prescribed dose, which follows a gradual escalation schedule. At Cured Pharmacy, Wegovy starts from £79.00 per month, representing competitive UK pricing with no hidden fees or subscription charges.

Wegovy treatment typically begins at 0.25mg weekly for four weeks, then increases progressively to 0.5mg, 1.0mg, 1.7mg, and finally the maintenance dose of 2.4mg weekly. Each dose strength requires a specific pen, and your UK prescriber will determine the appropriate escalation timeline based on your tolerance and weight loss progress [2].

Unlike some providers, Cured Pharmacy displays all pricing before your consultation begins. This transparent approach means you'll know your monthly Wegovy cost upfront, with no surprise charges at checkout. All prices include the medication, clinical assessment, and discreet UK delivery.

What's Included In Your Wegovy Cost

Your Wegovy monthly cost at Cured Pharmacy includes a free online consultation with a UK-registered prescriber (typically completed in under 3 minutes), the genuine MHRA-licensed Wegovy pen at your prescribed dose strength, and discreet packaging delivered directly to your address. There are no additional consultation fees, delivery charges, or subscription commitments.

We also provide ongoing clinical support throughout your treatment. If you experience side effects or have questions about dose escalation, our UK clinical team is available via phone (+44 116 4646009) during business hours to ensure safe, effective treatment outcomes.

How Wegovy (Semaglutide) Works For Weight Loss

Wegovy contains semaglutide, a GLP-1 (glucagon-like peptide-1) receptor agonist that mimics a natural hormone your body produces after eating. This medication works through three primary mechanisms: reducing appetite by acting on brain regions that control hunger, slowing gastric emptying to increase feelings of fullness, and improving blood sugar regulation [3].

In the landmark STEP 1 clinical trial, participants using Wegovy 2.4mg weekly alongside lifestyle modifications achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% in the placebo group [3]. These results represent some of the most significant weight loss outcomes achieved with pharmacological intervention.

Semaglutide's once-weekly injection schedule offers practical advantages over daily treatments. The medication reaches steady-state levels in your bloodstream after approximately 4-5 weeks, providing consistent appetite suppression throughout the week. This extended action is possible due to semaglutide's molecular modifications that slow its breakdown in the body [1].

Wegovy Dose Escalation Schedule And Timeline

Wegovy follows a structured dose escalation protocol designed to minimise gastrointestinal side effects while your body adjusts to semaglutide. The standard NHS-recommended schedule begins at 0.25mg weekly for month one, increases to 0.5mg for month two, 1.0mg for month three, 1.7mg for month four, and reaches the maintenance dose of 2.4mg from month five onwards [2].

This gradual escalation is clinically important. Patients who skip dose steps or escalate too quickly experience significantly higher rates of nausea, vomiting, and treatment discontinuation. Your UK prescriber may adjust this timeline if you experience persistent side effects, sometimes extending a dose level for an additional month before progressing.

Most patients reach the full 2.4mg maintenance dose by month five, though some may require longer escalation periods. Clinical trials showed that weight loss continues throughout the escalation phase, with the most significant reductions typically occurring once patients reach higher dose strengths [3].

What If I Miss A Dose?

If you miss your weekly Wegovy injection and it's been less than 5 days since your scheduled dose, take it as soon as you remember. If more than 5 days have passed, skip the missed dose and resume your normal schedule the following week. Never double up on doses to compensate for a missed injection.

Patients who miss multiple consecutive doses may need to restart at a lower dose strength to avoid severe gastrointestinal reactions. Contact your prescriber if you've missed two or more weekly injections, as they may recommend temporarily reducing your dose before returning to your previous strength.

Wegovy Eligibility: Who Can Use Semaglutide For Weight Loss

In the UK, Wegovy is licensed for adults with a body mass index (BMI) of 30 kg/m² or greater, or a BMI of 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea. NICE guidance specifies these criteria to ensure the medication is prescribed to patients who will benefit most from pharmacological intervention [4].

Your UK prescriber will assess several factors during your consultation, including your current BMI, weight loss history, existing medical conditions, current medications, and any contraindications. Wegovy is not suitable for patients with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or severe gastrointestinal disease [2].

Pregnant or breastfeeding women should not use Wegovy, as semaglutide crosses the placental barrier and may appear in breast milk. If you're planning pregnancy, discontinue Wegovy at least 2 months before conception to allow complete medication clearance. Women of childbearing age should use reliable contraception throughout treatment.

Common Wegovy Side Effects And Management Strategies

The most frequently reported side effects with Wegovy are gastrointestinal: nausea (44% of patients), diarrhoea (30%), vomiting (24%), constipation (24%), and abdominal pain (20%) in clinical trials [3]. These effects typically emerge during dose escalation and diminish as your body adapts to semaglutide, usually within 4-8 weeks.

To minimise nausea, eat smaller, more frequent meals rather than large portions, avoid high-fat or heavily spiced foods, and stay well-hydrated throughout the day. Taking your injection in the evening rather than morning may help, as peak nausea often occurs 1-3 days post-injection. Ginger tea and avoiding lying down immediately after eating can also provide relief.

More serious but rare side effects include pancreatitis (inflammation of the pancreas), gallbladder problems, and changes in vision for patients with diabetic retinopathy. Seek immediate medical attention if you experience severe abdominal pain that doesn't resolve, persistent vomiting, or sudden vision changes. Your prescriber will monitor for these complications during follow-up assessments [2].

Some patients report injection site reactions such as redness, itching, or mild swelling. Rotate your injection sites between your abdomen, thigh, and upper arm each week to minimise localised reactions. Allow the pen to reach room temperature before injecting, and ensure you're using proper injection technique as demonstrated in the patient information leaflet.

When To Contact Your Prescriber

Contact your UK prescriber if you experience persistent vomiting lasting more than 24 hours, severe abdominal pain, signs of pancreatitis (upper abdominal pain radiating to your back), symptoms of gallstones (pain in the upper right abdomen, especially after eating), or unexplained rapid heartbeat. These symptoms may require dose adjustment or treatment discontinuation.

Also reach out if gastrointestinal side effects don't improve after 4 weeks at a given dose, or if you're unable to maintain adequate nutrition and hydration due to persistent nausea. Your prescriber may recommend extending your current dose level before escalating, or prescribing anti-nausea medication to support your treatment.

Scientific References

1. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 0.25 mg solution for injection in pre-filled pen - Summary of Product Characteristics. GOV.UK. https://products.mhra.gov.uk/ [accessed 13 August 2026]
2. Electronic Medicines Compendium. (2024). Wegovy 2.4mg solution for injection in pre-filled pen. Datapharm Ltd. https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
4. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on multiple factors including diet, exercise, and adherence to treatment. Wegovy is not suitable for everyone, and your prescriber will determine eligibility based on your medical history and current health status.